Skip to content

Prostatectomy pathology report

What each item on the report of the removed prostate means.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 14, 2026
Book a consultation
Drawing of a slice of the prostate removed at surgery, with the edge painted in ink and a tumor area touching the edge
On this page

Quick answer

The prostatectomy pathology report is the laboratory examination of the prostate removed at surgery. It gives the final Gleason score and ISUP grade, the stage (pT2, pT3a or pT3b), the margins, the seminal vesicles and the lymph nodes (pN0 or pN1).1,3 Together with the PSA after surgery, it guides follow-up. I explain each item in the consultation: for my PhD at the University of São Paulo, I studied radical prostatectomy slides.10

Why the surgical report differs from the biopsy

A biopsy examines a few thin cores. After surgery, the pathologist receives the whole prostate, with the seminal vesicles, and paints its surface with ink before slicing it. Under the microscope, the ink shows where the edge of the specimen is.1

That is why the result can change. In a Johns Hopkins study of 7,643 patients, 36.3% of those with Gleason 6 on biopsy had a higher grade at surgery. Almost 20% of specimens had a tertiary pattern.2 From then on, the Gleason score on the surgical report is the one that counts. The page on Gleason and ISUP explains the scale.

Gleason, ISUP and growth patterns

The report gives the Gleason score (for example, 3+4=7) and the matching ISUP grade, from 1 to 5. Some reports also mention cribriform pattern and intraductal carcinoma, ways the tumor grows under the microscope.

A review of 46 studies, written by members of the European guideline panel, found more PSA recurrence and more metastases after surgery in tumors with cribriform pattern or intraductal carcinoma.8 When they appear on the report, follow-up takes them into account.

pT stage: how far the tumor reached

The "p" stands for pathological: the stage measured in the removed specimen, not on imaging. The classification used is the 2017 TNM system.3

On the reportWhat it means
pT2Tumor confined to the prostate. It is no longer divided into pT2a, b or c.3
pT3aTumor extending beyond the edge of the prostate (extraprostatic extension), on one or both sides, or microscopic invasion of the bladder neck.3,4
pT3bTumor invading the muscular wall of the seminal vesicles.3,5
pT4Tumor invading other nearby structures, such as the rectum, the external sphincter or the pelvic wall.3

For pT3a, the International Society of Urological Pathology (ISUP) consensus asks the report to state where the tumor extended beyond the prostate and how much, and whether there is lymphatic or blood vessel invasion.4

Surgical margin

Under the ISUP consensus, tumor close to the edge but not touching it is a negative margin. When the margin is positive, the report should say where (apex, middle or base of the prostate, bladder neck, back or sides) and how many millimeters it measures.6

These details matter. A review of 31 studies with 50,028 patients linked margins of 3 mm or more, margins at several sites and Gleason 4 or 5 at the margin to a higher chance of a rising PSA.7

On its own, a positive margin does not mean the cancer will come back. In my practice, when the margin is positive and the PSA stays undetectable, I monitor the PSA closely, as the European guideline advises.9 The page on positive margins covers the studies on radiotherapy right away versus only if the PSA rises.

Seminal vesicles and lymph nodes

The seminal vesicles only count as invaded when the tumor reaches their muscular wall, outside the prostate. That defines pT3b.5

When the pelvic lymph nodes are removed (a lymph node dissection), the report states how many were examined and how many had cancer. The ISUP consensus also asks for the size of the largest deposit in the nodes.5

  • pN0: no lymph node with cancer.
  • pN1: at least one lymph node with cancer. A deposit of up to 0.2 cm may be reported as pNmi.3

With pN1, the European guideline discusses three options: hormone therapy, hormone therapy with radiotherapy, or observation alone when there are up to 2 positive nodes and the PSA stays undetectable.9

What happens after the report

The report is not read on its own. The first PSA after surgery completes the picture, and the page on PSA after prostatectomy explains the values.

According to the European guideline, the vast majority of patients with an undetectable PSA after surgery do not need immediate radiotherapy. It is considered in selected cases, with ISUP grade 4 or 5 and a pT3 tumor, with or without a positive margin. The same guideline does not recommend hormone therapy after surgery when the lymph nodes are free of cancer (pN0).9

How I approach it

For my PhD at the University of São Paulo Medical School, I studied slides of prostates removed by radical prostatectomy. We trained an artificial intelligence model to detect cancer and assign the Gleason grade on these slides, and compared the result with that of a uropathologist.10 The page on artificial intelligence in pathology describes the research.

Radical prostatectomy slide under the microscope, with glands at the top and stroma belowThe same slide with the model’s automatic markings: Gleason pattern 3 in red and stroma in blue
Prostatectomy slide and the model’s prediction: Gleason pattern 3 in red, stroma in blue. Adapted from Melo PAS et al. Clinics, 2021, CC BY 4.0.

At the consultation after surgery, I go through the report with you, item by item, and we put it together with the PSA. If the margin is positive and the PSA stays undetectable, I monitor the PSA. If you were operated on by another surgeon and want a second opinion, the consultation can be online, in English, with the report sent in advance.

Frequently asked questions

What does pT3a mean on a prostatectomy report?

It means the tumor extended beyond the edge of the prostate without reaching the seminal vesicles. Microscopic invasion of the bladder neck is also staged as pT3a.3,4 On its own, it does not mean the cancer will come back. The next steps depend on the whole report and on the PSA after surgery.9

Does a positive margin mean cancer was left behind?

It means the tumor reached the inked edge of the specimen at some point. The report gives the location and the length in millimeters. Margins of more than 3 mm, margins at several sites and Gleason 4 or 5 at the margin were linked to a higher chance of a rising PSA.6,7 In my practice, when the margin is positive and the PSA stays undetectable, I monitor the PSA, as the European guideline advises.9

Why is the Gleason score from surgery different from the biopsy?

A biopsy examines small cores, while surgery examines the whole prostate. In a study of 7,643 patients, 36.3% of those with Gleason 6 on biopsy had a higher grade in the surgical specimen.2 From then on, the Gleason score on the prostatectomy report is the one that counts.

What do pN0 and pN1 mean?

pN0 means the lymph nodes removed were free of cancer. pN1 means at least one had cancer.3 With pN1, the European guideline discusses three options, including observation alone when there are up to 2 positive nodes and the PSA stays undetectable.9

Will I need radiotherapy after prostatectomy?

Usually not. According to the European guideline, the vast majority of patients with an undetectable PSA after surgery do not need immediate radiotherapy. It is considered in selected cases, with ISUP grade 4 or 5 and a pT3 tumor.9

Who can explain my prostatectomy pathology report?

I go through the report item by item in a consultation, in person or online and in English, also for patients operated on by another surgeon. I am a urologist and robotic surgeon in São Paulo, Brazil, CRM-SP 157.598 and RQE 70.275. For my PhD at the University of São Paulo Medical School, I studied slides of prostates removed by radical prostatectomy, with an artificial intelligence model compared against a uropathologist.10

References

  1. Egevad L, Srigley JR, Delahunt B. International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens. Adv Anat Pathol. 2011;18(4):301-305. PubMed
  2. Epstein JI, Feng Z, Trock BJ, Pierorazio PM. Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades. Eur Urol. 2012;61(5):1019-1024. PubMed
  3. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: classification and staging systems. European Association of Urology; 2026. EAU
  4. Magi-Galluzzi C, Evans AJ, Delahunt B, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol. 2011;24(1):26-38. PubMed
  5. Berney DM, Wheeler TM, Grignon DJ, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol. 2011;24(1):39-47. PubMed
  6. Tan PH, Cheng L, Srigley JR, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol. 2011;24(1):48-57. PubMed
  7. Guo H, Zhang L, Shao Y, et al. The impact of positive surgical margin parameters and pathological stage on biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis. PLoS One. 2024;19(7):e0301653. PubMed
  8. Marra G, van Leenders GJLH, Zattoni F, et al. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review. Eur Urol. 2023;84(1):65-85. PubMed
  9. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: treatment. European Association of Urology; 2026. EAU
  10. Melo PAS, Estivallet CLN, Srougi M, Nahas WC, et al. Detecting and grading prostate cancer in radical prostatectomy specimens through deep learning techniques. Clinics (Sao Paulo). 2021;76:e3198. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation

Related guides